First Majestic 2026 Outlook Reiterates Scale, But Key Tests Remain

What happened

First Majestic's September 21, 2026 outlook highlights continued operational scale from the Gatos Silver acquisition and record 2025 silver production of 15 million ounces, which aligns with previously reported figures of 15.4 million ounces and record revenue. The news piece appears promotional, focusing on past success without addressing the company's forward challenges. The two near-term catalysts from the April 2026 master report—the first higher-rate dividend payment under the 2%-of-revenue policy expected in May 2026 and confirmation that 2026 capex stays within the $213–$236 million guidance—remain unresolved. As of April 2026, the stock was rated WAIT with conviction 3.0, as valuation already embedded strong metals prices and execution, leaving little room for error. This September news does not provide new evidence on dividend credibility or capital discipline, so the investment thesis remains unchanged.

Implication

The article from The Motley Fool appears promotional, focusing on past success without addressing the company's forward challenges. For investors, the key near-term events remain the May and August 2026 dividend declarations, which will test the board's commitment to the 2%-of-revenue framework, and interim capex updates to verify spending remains within guidance. If the company pays the expected dividends and holds capex, confidence in the thesis improves, but if it deviates, the stock could de-rate quickly given its high valuation multiples. Current holders should maintain positions only if they are comfortable with the silver price risk, while potential buyers should wait for evidence of capital discipline at a more attractive entry point near $18. The news does not provide that evidence, so the WAIT rating is reaffirmed.

Thesis delta

The thesis delta is neutral: the new article does not introduce any material new information beyond what was already known in the master report. The company's record 2025 production and profitability are already reflected in the current price, and the key uncertainties regarding dividend sustainability and capex overruns remain unresolved. Therefore, the WAIT rating and conviction level of 3.0 are unchanged.